WASHINGTON, June 13 -- Food and Drug Administration has issued a notice called: Rare Disease Innovation, Science, and Exploration Public Workshop Series; Request for Comments.
The notice was published in the Federal Register on June 13 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following request for comments for a future public workshop series entitled "Rare disease Innovation, Science, and Exploration (RISE) Workshop." The purpose of the public workshops will be to focus on challenges that are common to multiple diseases or a class of diseases, and for which evolving science offers innovative solutions. Th...